Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis

Completed · Phase 4

Conditions studied: Blepharitis

In brief

The purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic solution, 1% on signs \& symptoms of blepharitis and tear cytokine and eyelid bacterial load levels

Key facts

Study ID

NCT00629941

Run by

Merck Sharp & Dohme LLC

People needed

25

Starts

2008-03-01

Last updated by the study team

2011-09-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of moderate to severe chronic blepharitis
• If female of childbearing potential, are non-pregnant and non-lactating

You may not qualify if…

• Had ocular surface surgery (LASIK, refractive, etc.) within the past year
• Unwilling to discontinue use of contact lenses during the study
• Have glaucoma
• Unable or unwilling to withhold the use of lid scrubs during the study
• Have a serious systemic disease or uncontrolled medical condition that in the judgment of the investigator could confound study assessments or limit compliance
• Currently using any preserved topical ocular medications (with the exception of unpreserved tear substitutes) at the time of entry into the study or during study participation

Where it is running

• Central Maine Eye Care — Lewiston, Maine, United States
• Ophthalmic Research Associates — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.